TY - JOUR AU - Birnbaum, H. AU - White, A. AU - Schiller, M. AU - Waldman, T. AU - Cleveland, J. AU - Setnik, B. PY - 2011 DA - 2011// TI - Societal costs of opioid abuse, dependence, and misuse in the United States JO - Value Heal VL - 12 ID - Birnbaum2011 ER - TY - JOUR AU - Florence, C. S. AU - Zhou, C. AU - Luo, F. AU - Xu, L. PY - 2016 DA - 2016// TI - The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013 JO - Med Care VL - 54 UR - https://doi.org/10.1097/MLR.0000000000000625 DO - 10.1097/MLR.0000000000000625 ID - Florence2016 ER - TY - JOUR AU - White, A. AU - Birnbaum, H. AU - Mareva, M. AU - Daher, M. AU - Vallow, S. AU - Schein, J. PY - 2005 DA - 2005// TI - Direct costs of opioid abuse in an insured population in the United States JO - J Manag Care Pharm VL - 11 ID - White2005 ER - TY - STD TI - Kuhn S, Schu M, Vogt I, Schmid M, Simmedinger R, Schlanstedt G, et al. Federal model project for heroin-assisted treatment [Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger - Band 3 - Psychosoziale Interventionen - Kosten und Nutzen der Behandlung - Transfer in die Versorgung]. Nomos Verlagsgesellschaft. 2008:1–294. ID - ref4 ER - TY - STD TI - Federal Opium Agency. Annual report on the OMT register January 2017 [Bericht zum Substitutionsregister]. 2017. ID - ref5 ER - TY - JOUR AU - Mattick, R. AU - Kimber, J. AU - Davoli, M. PY - 2003 DA - 2003// TI - Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence JO - Cochrane Database Syst Rev VL - 2 ID - Mattick2003 ER - TY - STD TI - Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014. ID - ref7 ER - TY - JOUR AU - Auriacombe, M. AU - Franques, P. AU - Tignol, J. PY - 2001 DA - 2001// TI - Deaths attributable to methadone vs buprenorphine in France JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.1.39 DO - 10.1001/jama.285.1.39 ID - Auriacombe2001 ER - TY - JOUR AU - Soyka, M. AU - Apelt, S. M. AU - Lieb, M. AU - Wittchen, H. -. U. PY - 2006 DA - 2006// TI - One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy JO - J Clin Psychopharmacol VL - 26 UR - https://doi.org/10.1097/01.jcp.0000245561.99036.49 DO - 10.1097/01.jcp.0000245561.99036.49 ID - Soyka2006 ER - TY - JOUR AU - Connock, M. AU - Juarez-Garcia, A. AU - Jowett, S. AU - Frew, E. AU - Liu, Z. AU - Taylor, R. PY - 2007 DA - 2007// TI - Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation JO - Health Technol Assess (Rockv) VL - 11 ID - Connock2007 ER - TY - STD TI - Hancock C, Menega H, King N, Andrilla H, E L, Schou P. National Rural Health Association Policy Brief: treating the rural opioid epidemic. National Rural Health Association (NRHA); 2017. p. 1–13. ID - ref11 ER - TY - JOUR AU - Swart, E. AU - Gothe, H. AU - Geyer, S. AU - Jaunzeme, J. AU - Maier, B. AU - Grobe, T. PY - 2015 DA - 2015// TI - Good practice of secondary data analysis (GPS): guidelines and recommendations, third revision 2012/2014 JO - Das Gesundheitswes VL - 77 UR - https://doi.org/10.1055/s-0035-1562981 DO - 10.1055/s-0035-1562981 ID - Swart2015 ER - TY - STD TI - Bauhoff S, Fischer L, Göpffarth D, Wuppermann AC. Plan Responses to Diagnosis- Based Payment: Evidence from Germany’s Morbidity-Based Risk Adjustment. Munich; 2017. Report No.: 6507. ID - ref13 ER - TY - STD TI - European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European Drug Report 2017. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2017. ID - ref14 ER - TY - JOUR AU - Langer, K. AU - Wittchen, H. -. U. AU - Bühringer, G. AU - Rehm, J. T. PY - 2011 DA - 2011// TI - Opioid maintenance treatment of opioid dependent patients: background JO - Care Structure and Challenges Suchtmed VL - 13 ID - Langer2011 ER - TY - STD TI - Erbas B, Fahrmbacher-Lutz C, Pogarell O, Stecker G, Tauber W, Wodarz N. Guideline for physicians for opioid maintanance treatment in opioid dependent patients, 4th edition [Leitfaden für Ärzte zur substitutionsgestützten Behandlung Opiatabhängiger, 4. vollständig überarbeitete Auflage]. Munich; 2018. ID - ref16 ER - TY - STD TI - German Medical Association Guideline of the German Medical Association fot the execution of opioid maintanance treatment in opioid dependent patients [Richtlinie der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opioidabhängiger], 02.10.2017. German Medical Association; 2017. p. 1–19. ID - ref17 ER - TY - STD TI - National Association of Statutory Health Insurance Funds (GKV-Spitzenverband), German Pharmacists’ Association (DAV). Contract on prices for compounds and preparations of compounds [Vertrag über die Preisbildung für Stoffe und Zubereitungen aus Stoffen, Hilfstaxe]. Berlin, Eschborn; 2010. p. 1–27. ID - ref18 ER - TY - JOUR AU - Wittchen, H. -. U. AU - Bühringer, G. AU - Rehm, J. T. AU - Soyka, M. AU - Träder, A. AU - Trautmann, S. PY - 2011 DA - 2011// TI - The social, clinical and treatment situation of opioid maintenance treatment in a prevalence sample of patients at baseline JO - Suchtmed VL - 13 ID - Wittchen2011 ER - TY - JOUR AU - Vogelmann, T. AU - Schwarz, R. AU - Trümper, D. PY - 2019 DA - 2019// TI - Financing of appropriate treatment and special support of opioid dependence through the morbidity-based risk adjustment system (Morbi-RSA) JO - Monit Versorgungsforsch VL - 12 UR - https://doi.org/10.24945/MVF.02.19.1866-0533.2093 DO - 10.24945/MVF.02.19.1866-0533.2093 ID - Vogelmann2019 ER - TY - JOUR AU - Kähm, K. AU - Laxy, M. AU - Schneider, U. AU - Rogowski, W. H. AU - Lhachimi, S. K. AU - Holle, R. PY - 2018 DA - 2018// TI - Health care costs associated with incident complications in patients with type 2 diabetes in Germany JO - Diabetes Care VL - 41 UR - https://doi.org/10.2337/dc17-1763 DO - 10.2337/dc17-1763 ID - Kähm2018 ER - TY - JOUR AU - Bode, K. AU - Vogel, R. AU - Walker, J. AU - Kröger, C. PY - 2017 DA - 2017// TI - Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data JO - Eur J Health Econ VL - 18 UR - https://doi.org/10.1007/s10198-016-0858-2 DO - 10.1007/s10198-016-0858-2 ID - Bode2017 ER - TY - JOUR AU - Häuser, W. AU - Schubert, T. AU - Scherbaum, N. AU - Tölle, T. PY - 2018 DA - 2018// TI - Guideline-recommended vs high-dose long-term opioid therapy for chronic noncancer pain is associated with better health outcomes JO - Pain VL - 159 UR - https://doi.org/10.1097/j.pain.0000000000001067 DO - 10.1097/j.pain.0000000000001067 ID - Häuser2018 ER - TY - JOUR AU - Barnett, P. G. PY - 2009 DA - 2009// TI - Comparison of costs and utilization among buprenorphine and methadone patients JO - Addiction VL - 104 UR - https://doi.org/10.1111/j.1360-0443.2009.02539.x DO - 10.1111/j.1360-0443.2009.02539.x ID - Barnett2009 ER - TY - JOUR AU - Srivastava, A. AU - Kahan, M. AU - Nader, M. PY - 2017 DA - 2017// TI - Primary care management of opioid use disorders: abstinence, methadone, or buprenorphine-naloxone? JO - Can Fam Physician VL - 63 ID - Srivastava2017 ER - TY - STD TI - National Association of Statutory Health Insurance Pysicians. Uniform Evaluation Scale 2016 [Internet]. Available from: https://www.kbv.de/html/online-ebm.php UR - https://www.kbv.de/html/online-ebm.php ID - ref26 ER - TY - STD TI - Jakovljevic M, Miјailovic Z, Popovska Jovicic B, Canovic P, Gajovic O, Jovanovic M, et al. Assessment of viral genotype impact to the cost-effectiveness and overall costs of Care for peg-Interferon-2α + Ribavirine treated chronic hepatitis C patients. Hepat Mon. 2013;13. ID - ref27 ER - TY - STD TI - Jakovljevic M, Jovanovic M, Rancic N, Vyssoki B, Djordjevic N. LAT Software Induced Savings on Medical Costs of Alcohol Addicts’ Care - Results from a Matched-Pairs Case-Control Study. Bruns H, editor. PLoS One. 2014;9:e111931. ID - ref28 ER - TY - JOUR AU - Hoffmann, F. AU - Bachmann, C. J. PY - 2014 DA - 2014// TI - Differences in sociodemographic characteristics, health, and health service use of children and adolescents according to their health insurance funds JO - Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz VL - 57 UR - https://doi.org/10.1007/s00103-013-1916-x DO - 10.1007/s00103-013-1916-x ID - Hoffmann2014 ER - TY - JOUR AU - Cartwright, W. S. PY - 2000 DA - 2000// TI - Cost-benefit analysis of drug treatment services: review of the literature JO - J Ment Health Policy Econ VL - 3 UR - https://doi.org/3.0.CO;2-0 DO - 3.0.CO;2-0 ID - Cartwright2000 ER - TY - JOUR AU - Lieb, M. AU - Wittchen, H. -. U. AU - Palm, U. AU - Apelt, S. M. AU - Siegert, J. AU - Soyka, M. PY - 2010 DA - 2010// TI - Psychiatric comorbidity in substitution treatment of opioid-dependent patients in primary care: prevalence and impact on clinical features JO - Heroin Addict Relat Clin Probl VL - 4 ID - Lieb2010 ER - TY - JOUR AU - Soyka, M. PY - 2017 DA - 2017// TI - Treatment of opioid dependence with buprenorphine: current update JO - Dialogues Clin Neurosci VL - 19 ID - Soyka2017 ER -